Apimeds Pharmaceuticals US
$2.84
9
-$0.11-3.73%Friday 02:28
Statistics
Day High
2.84
Day Low
2.84
52W High
7.29
52W Low
0.6571
Volume
3
Avg. Volume
-
Mkt Cap
4.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-6MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow APUS.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Show More
CEO
ISIN
US03771D1028
Listings
0 Comments
Share your thoughts
FAQs
What is Apimeds Pharmaceuticals US stock price today?▼
The current price of APUS.BOATS is $2.84 USD — it has decreased by -3.73% in the past 24 hours. Watch Apimeds Pharmaceuticals US stock price performance more closely on the chart.
What is Apimeds Pharmaceuticals US stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Apimeds Pharmaceuticals US stocks are traded under the ticker APUS.BOATS.
What is Apimeds Pharmaceuticals US market cap?▼
Today Apimeds Pharmaceuticals US has the market capitalization of 4.29M
What is Apimeds Pharmaceuticals US revenue for the last year?▼
Apimeds Pharmaceuticals US revenue for the last year amounts to 0 USD.
What is Apimeds Pharmaceuticals US net income for the last year?▼
APUS.BOATS net income for the last year is -6M USD.
In which sector is Apimeds Pharmaceuticals US located?▼
Apimeds Pharmaceuticals US operates in the Other sector.
When did Apimeds Pharmaceuticals US complete a stock split?▼
The last stock split for Apimeds Pharmaceuticals US was on July 24, 2026 with a ratio of 1:10.